Repatha

Supreme Court rules against Amgen bid to revive cholesterol drug patents
Supreme Court rules against Amgen bid to revive cholesterol drug patents
KFGO/Reuters
Supreme Court
Amgen
Sanofi
Regeneron
patents
Repatha
legal
Flag link:
Amgen files brief to Supreme Court ahead of oral arguments — with industry amicus support
Amgen files brief to Supreme Court ahead of oral arguments — with industry amicus support
Endpoints
Amgen
Sanofi
Regeneron
Supreme Court
legal
innovation
patents
Repatha
Praluent
Flag link:
Amgen's Supreme Court bid answered in long-running Repatha patent feud against Sanofi, Regeneron
Amgen's Supreme Court bid answered in long-running Repatha patent feud against Sanofi, Regeneron
Fierce Pharma
Amgen
Repatha
patents
Supreme Court
Sanofi
Regeneron
Flag link:
Biden admin says Supreme Court should reject Amgen's petition to take up Repatha patent case
Biden admin says Supreme Court should reject Amgen's petition to take up Repatha patent case
Fierce Pharma
Amgen
patents
Supreme Court
Repatha
Sanofi
Regeneron
Flag link:
Regeneron's cholesterol drug war heats up with lawsuit over Amgen's 'illegal' bundling scheme
Regeneron's cholesterol drug war heats up with lawsuit over Amgen's 'illegal' bundling scheme
Fierce Pharma
Regeneron
Amgen
FDA
antitrust
legal
Repatha
Praluent
Flag link:
Amgen asks Supreme Court to take up its high-profile PCSK9 patent case against Sanofi and Regeneron
Amgen asks Supreme Court to take up its high-profile PCSK9 patent case against Sanofi and Regeneron
Fierce Pharma
Amgen
Sanofi
Regeneron
patents
Supreme Court
Repatha
Flag link:
Amgen's Otezla, Repatha and biosimilars put on notice, with challenging years ahead
Amgen's Otezla, Repatha and biosimilars put on notice, with challenging years ahead
Fierce Pharma
Amgen
biosimilars
Otezla
Repatha
Flag link:
Merck’s Anti-Cholesterol Drug Threatens Esperion, Other PCSK9 Inhibitor Makers
Merck’s Anti-Cholesterol Drug Threatens Esperion, Other PCSK9 Inhibitor Makers
BioSpace
Merck
PCSK9 inhibitors
Amgen
Repatha
Esperion
Sanofi
Regeneron
Praluent
Flag link:
Amgen receives FDA approval for Repatha to treat pediatric HeFH patients
Amgen receives FDA approval for Repatha to treat pediatric HeFH patients
Pharmaceutical Business Review
Amgen
Repatha
FDA
pediatric
HeFH
Flag link:
Amgen dealt another blow in closely watched PCSK9 patent case against Sanofi, Regeneron
Amgen dealt another blow in closely watched PCSK9 patent case against Sanofi, Regeneron
Fierce Pharma
Amgen
PCSK9 inhibitors
Sanofi
Regeneron
patents
Repatha
Flag link:
Amgen loses appeal in patent suit against Sanofi/Regeneron’s Praluent. It’s a bummer for Bristol Myers Squibb and Merck, too
Amgen loses appeal in patent suit against Sanofi/Regeneron’s Praluent. It’s a bummer for Bristol Myers Squibb and Merck, too
Endpoints
Amgen
patents
Sanofi
Regeneron
Praluent
Repatha
Merck
Flag link:
ESC: Amgen chases pediatric use for cholesterol-busting PCSK9 med Repatha
ESC: Amgen chases pediatric use for cholesterol-busting PCSK9 med Repatha
Fierce Pharma
ESC
Amgen
Repatha
Sanofi
Regeneron
Praluent
cholesterol
Flag link:
ACC: Amgen's Repatha cuts cholesterol in rarely studied HIV patients
ACC: Amgen's Repatha cuts cholesterol in rarely studied HIV patients
Fierce Pharma
ACC
Repatha
HIV
clinical trials
Amgen
Flag link:
Two Big Drug Flops Show How Health-Care Economics Have Changed
Two Big Drug Flops Show How Health-Care Economics Have Changed
Bloomberg
drug pricing
Sanofi
Amgen
Praluent
Repatha
Flag link:
AHA: Amgen's Repatha tied to greater risk reduction in high-risk heart attack patients
AHA: Amgen's Repatha tied to greater risk reduction in high-risk heart attack patients
Fierce Pharma
AHA
Amgen
Repatha
PCSK9 inhibitor
heart attacks
Flag link:
Amgen slashes price tag on cholesterol medicine Repatha by 60% for 2020
Amgen slashes price tag on cholesterol medicine Repatha by 60% for 2020
Yahoo/Reuters
Amgen
drug pricing
Repatha
Flag link:
MedCo's PCSK9 challenger steals the show at ESC with winning data
MedCo's PCSK9 challenger steals the show at ESC with winning data
Fierce Pharma
Medicines Company
ESC
PCSK9 inhibitors
inclisiran
Repatha
Praluent
European Society of Cardiology
Flag link:
Sanofi, Regeneron score win against Amgen patents on PCSK9 med Repatha
Sanofi, Regeneron score win against Amgen patents on PCSK9 med Repatha
Fierce Pharma
Sanofi
Regeneron
Amgen
PCSK9 inhibitors
patents
Praluent
Repatha
Flag link:
Lackluster Amgen, Sanofi PCSK9 drugs could be under major threat from a new rival: analyst
Lackluster Amgen, Sanofi PCSK9 drugs could be under major threat from a new rival: analyst
Fierce Pharma
Amgen
Regeneron
Sanofi
Praluent
Repatha
Medicines Company
PCSK9 inhibitors
inclisiran
Flag link:
German court blocks sale of Sanofi, Regeneron cholesterol drug
German court blocks sale of Sanofi, Regeneron cholesterol drug
Biopharma Dive
patents
Amgen
Sanofi
Regeneron
Germany
Praluent
Repatha
Flag link:

Pages